These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. Hüe S, Cacoub P, Renou C, Halfon P, Thibault V, Charlotte F, Picon M, Rifflet H, Piette JC, Pol S, Caillat-Zucman S. J Infect Dis; 2002 Jul 01; 186(1):106-9. PubMed ID: 12089669 [Abstract] [Full Text] [Related]
10. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Idèo G. Hepatology; 2000 Jun 01; 31(6):1345-50. PubMed ID: 10827162 [Abstract] [Full Text] [Related]
12. Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients. Pan N, Chen K, Qiu J, Sun H, Xu J, Miao F, Shi Q, Jiang W, Jin H, He Y, Xie W, Zhang J. Hum Immunol; 2013 Jun 01; 74(6):758-63. PubMed ID: 23459080 [Abstract] [Full Text] [Related]
13. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Gambelunghe G, Gerli R, Bocci EB, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. Rheumatology (Oxford); 2005 Mar 01; 44(3):287-92. PubMed ID: 15522921 [Abstract] [Full Text] [Related]
14. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. Nowak J, Kalinka-Warzocha E, Juszczyński P, Mika-Witkowska R, Zajko M, Graczyk-Pol E, Coiffier B, Salles G, Warzocha K. Tissue Antigens; 2008 Jan 01; 71(1):16-26. PubMed ID: 17971052 [Abstract] [Full Text] [Related]
15. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Murata H, Shimizu Y, Yamazaki T, Fushimi H, Kotoh K, Kasahara A, Fusamoto H, Kamada T. J Med Virol; 1996 Jan 01; 48(1):1-7. PubMed ID: 8825703 [Abstract] [Full Text] [Related]
16. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. Aikawa T, Kojima M, Onishi H, Tamura R, Fukuda S, Suzuki T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. J Med Virol; 1996 Aug 01; 49(4):274-8. PubMed ID: 8877758 [Abstract] [Full Text] [Related]
17. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A. Fdez-Morera JL, Tunon A, Rodriguez-Rodero S, Rodrigo L, Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Lahoz CH, Lopez-Larrea C. Tissue Antigens; 2006 May 01; 67(5):409-14. PubMed ID: 16671949 [Abstract] [Full Text] [Related]
18. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Pekow JR, Bhan AK, Zheng H, Chung RT. Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861 [Abstract] [Full Text] [Related]
19. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, Rodrigo L, Rodrigo P, González S, Lahoz CH, Lopez-Larrea C. Tissue Antigens; 2008 Jul 15; 72(1):54-9. PubMed ID: 18588574 [Abstract] [Full Text] [Related]
20. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Hepatology; 2001 Oct 15; 34(4 Pt 1):625-30. PubMed ID: 11584356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]